Professional Documents
Culture Documents
T chc Y t Th gii
2. Oxytocin (10 n v quc t, tim tnh mch hoc tim bp) l thuc co hi t cung c
khuyn co phng nga bng huyt sau sanh. (Khuyn co mc mnh, bng chng
mc trung bnh)
Oxytocin (10 IU, IV/IM) is the recommended uterotonic drug for the prevention of PPH. (Strong recommendation, moderate-quality
evidence)
X l dy rn v xoa t cung
5. Ti cc c s m c nhn vin y t c k nng sanh thun thc, nu nh nhn vin y
t v sn ph u nhn nh rng vic gim mt lng nh mu mt v thu ngn mt t thi
gian ca giai on 3 ca chuyn d th vic ko dy rn c kim sot c khuyn co thc
hin cho cc cuc sanh ng m o (Khuyn co mc yu, bng chng mc mnh)
In settings where skilled birth attendants are available, CCT is recommended for vaginal births if the care provider and the parturient
woman regard a small reduction in blood loss and a small reduction in the duration of the third stage of labour as important (Weak
recommendation, high-quality evidence)
9. Duy tr xoa bp t cung khng c khuyn co nh l mt bin php phng nga bng
huyt sau sanh nhng sn ph c oxytocin d phng (Khuyn co yu, bng chng mc
thp)
Sustained uterine massage is not recommended as an intervention to prevent PPH in women who have received prophylactic oxytocin.
(Weak recommendation, low-quality evidence)
Bin dch: B mn Ph Sn, H YD TP.HCM v Phng K hoch tng hp, Bnh vin Ph Sn Hng Vng. 2013
Lu hnh ni b
10. nh gi trng lc c t cung qua thnh bng sau sanh pht hin sm t cung c
khuyn co cho tt c cc sn ph. (Khuyn co mc mnh, bng chng mc rt thp)
Postpartum abdominal uterine tonus assessment for early identification of uterine atony is recommended for all women. (Strong
recommendation, very-low-quality evidence)
Bin dch: B mn Ph Sn, H YD TP.HCM v Phng K hoch tng hp, Bnh vin Ph Sn Hng Vng. 2013
Lu hnh ni b
14. Trong trng hp khng c oxytocin, hoc trong trng hp vic kim sot chy mu khng
p ng vi oxytocin, s dng ergometrine ng tnh mch, oxytocin v ergometrine phi
hp vi hm lng c nh, hoc prostaglandin (bao gm c misoprostol ngm di li,
800g) c khuyn co. (Khuyn co mc mnh, bng chng mc thp)
If intravenous oxytocin is unavailable, or if the bleeding does not respond to oxytocin, the use of intravenous ergometrine, oxytocinergometrine fixed dose, or a prostaglandin drug (including sublingual misoprostol, 800 g) is recommended. (Strong recommendation, lowquality evidence)
16. S dng acid tranexamic c khuyn co iu tr bng huyt sau sanh nu oxytocin v
cc thuc co hi t cung khc khng ngn c mu chy hoc nguyn nhn chy mu c th
phn no l do nguyn nhn tn thng sinh dc. (Khuyn co mc yu, bng chng mc
trung bnh)
The use of tranexamic acid is recommended for the treatment of PPH if oxytocin and other uterotonics fail to stop bleeding or if it is thought
that the bleeding may be partly due to trauma. (Weak recommendation, moderate-quality evidence)
19. Nu cc phng php khc tht bi v bnh vin c sn ngun lc cn thit, vic thuyn tc
ng mch t cung c khuyn co nh l mt bin php iu tr bng huyt sau sanh do
t cung. (Khuyn co mc yu, bng chng mc rt thp)
If other measures have failed and if the necessary resources are available, the use of uterine artery embolization is recommended as a
treatment for PPH due to uterine atony. (Weak recommendation, very-low-quality evidence)
20. Nu mu vn khng ngng chy d s dng cc thuc co hi t cung v cc bin php can
thip bo tn khc (nh xoa bp t cung, chn bng), th vic thc hin cc bin php can
thip ngoi khoa c khuyn co. (Khuyn co mc mnh, bng chng mc rt thp)
If bleeding does not stop in spite of treatment using uterotonics and other available conservative interventions (e.g. uterine massage,
balloon tamponade), the use of surgical interventions is recommended. (Strong recommendation, very-low-quality evidence)
21. Phng php chn t cung bng hai tay c khuyn co l mt bin php tm thi trong
thi gian ch i c th thc hin c cc iu tr thch hp cho tnh trng bng huyt sau
sanh do t cung sau sanh ng m o. (Khuyn co mc yu, bng chng mc rt
thp)
The use of bimanual uterine compression is recommended as a temporizing measure until appropriate care is available for the treatment of
PPH due to uterine atony after vaginal delivery. (Weak recommendation, very-low-quality evidence)
Bin dch: B mn Ph Sn, H YD TP.HCM v Phng K hoch tng hp, Bnh vin Ph Sn Hng Vng. 2013
Lu hnh ni b
22. Phng php chn ng mch t cung qua thnh bng iu tr bng huyt sau sanh do
t cung sau sanh ng m o c khuyn co l mt bin php tm thi trong thi gian ch
i c th thc hin c cc iu tr thch hp. (Khuyn co mc yu, bng chng mc
rt thp)
The use of external aortic compression for the treatment of PPH due to uterine atony after vaginal birth is recommended as a temporizing
measure until appropriate care is available. (Weak recommendation, very-low-quality evidence)
24. Chn gc lng t cung khng c khuyn co iu tr bng huyt sau sanh do t cung
sau sanh ng m o. (Khyn co mc yu, bng chng mc rt thp)
The use of uterine packing is not recommended for the treatment of PPH due to uterine atony after vaginal birth. (Weak recommendation,
very-low-quality evidence)
26. Vic s dng ergometrine khi nhau cha bong khng c khuyn co v vic ny c th lm
cho t cung co cng lin tc c th gy chm tr s tng xut nhau. (Khuyn co mc
yu, bng chng mc rt thp)
The use of ergometrine for the management of retained placenta is not recommended as this may cause tetanic uterine contractions which
may delay the expulsion of the placenta. (Weak recommendation, very-low-quality evidence)
27. Vic s dng prostaglandin E2 alpha (dinoprostone hoc sulprostone) iu tr nhau khng
bong khng c khuyn co. (Khuyn co mc yu, bng chng mc rt thp)
The use of prostaglandin E2 alpha (dinoprostone or sulprostone) for the management of retained placenta is not recommended. (Weak
recommendation, very-low-quality evidence)
28. Dng khng sinh mt liu duy nht (ampicillin hoc cephalosporin th h th nht) c
khuyn co trong trng hp c thc hin bc nhau bng tay. (Khuyn co mc yu, bng
chng mc rt thp)
A single dose of antibiotics (ampicillin or first-generation cephalosporin) is recommended if manual removal of the placenta is practised.
(Weak recommendation, very-low-quality evidence)
Bin dch: B mn Ph Sn, H YD TP.HCM v Phng K hoch tng hp, Bnh vin Ph Sn Hng Vng. 2013
Lu hnh ni b
Hp C: T chc chm sc
29. Khuyn co s dng phc iu tr chnh thng ca c s thc hin phng trnh v iu
tr bng huyt sau sanh. (Khuyn co mc yu, bng chng mc trung bnh)
The use of formal protocols by health facilities for the prevention and treatment of PPH is recommended. (Weak recommendation,
moderate-quality evidence)
30. Cho mi c s y t tuyn di, khuyn co s dng phc iu tr chnh thng dng cho
chuyn bnh nhn ln tuyn trn. (Khuyn co mc yu, bng chng mc rt thp)
The use of formal protocols for referral of women to a higher level of care is recommended for health facilities. (Weak recommendation,
very-low-quality evidence)
31. Khuyn co s dng cc phng php m phng iu tr bng huyt sau sanh trong cc
chng trnh hun luyn hin hu v tin lm sng. (Khuyn co mc yu, bng chng
mc rt thp)
The use of simulations of PPH treatment is recommended for pre-service and in-service training programmes. (Weak recommendation,
very-low-quality evidence)
32. Theo di vic s dng thuc co hi t cung sau sanh nhm mc ch phng trnh bng huyt
sau sanh phng nga bng huyt sau sanh c khuyn co nh l mt ch t cho nh
gi. (Khuyn co mc yu, bng chng mc rt thp)
Monitoring the use of uterotonics after birth for the prevention of PPH is recommended as a process indicator for programmatic evaluation.
(Weak recommendation, very-low-quality evidence)
Bin dch: B mn Ph Sn, H YD TP.HCM v Phng K hoch tng hp, Bnh vin Ph Sn Hng Vng. 2013
Lu hnh ni b